PBH Prestige Consumer Healthcare Inc.

$46.96 +1.89%

Healthcare · Pharmaceutical Preparations

Prestige Consumer Healthcare Inc. (PBH) is a healthcare company in the Pharmaceutical Preparations industry, with a market capitalization of $2.2 billion. Shares last traded at $46.96, 45.0% below their 52-week high. Over the past year the stock is down 43.8%. PBH trades at a price-to-earnings ratio of 11.69, below the Pharmaceutical Preparations median of 16.82. Net profit margin is 17.5%, above the peer median of -0.1%. Revenue declined 4.3% year over year.

Market Cap

$2.2B

Shares Out

47.4M

EPS (TTM)

$8.82

P/E Ratio

5.32

P/S Ratio

2.04

P/B Ratio

1.18

Dividend / Share

—

Dividend Yield

—

52-Week High

$85.42

52-Week Low

$42.89

Volume

53,639

Avg Vol (3m)

44,588.111

Performance

-1.42%

+1.14%

-21.80%

-23.83%

YTD

-23.31%

-43.83%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

42.88

SMA (50)

$51.56

SMA (200)

$60.06

Price vs SMA50

-8.93%

Price vs SMA200

-21.81%

ATR (14)

$2.18

Financials

Revenue

$1.1B

Net Income

$190M

Gross Margin

54.7%

Operating Margin

28.4%

Net Margin

17.5%

Return on Equity

10.1%

Return on Assets

5.4%

Current Ratio

3.57

Debt / Equity

0.53

Revenue Growth (YoY)

-4.3%

Latest reported annual period ending 2026-03-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
FY 2026	$3.91	2026-05-14
Q3 2026	$2.78	2026-02-05
Q2 2026	$1.81	2025-11-06
Q1 2026	$0.95	2025-08-07
FY 2026	$4.29	2026-05-14
Q3 2026	$3.28	2026-02-05

Full earnings history →

Pharmaceutical Preparations peers

PBH vs 14 industry peers (Pharmaceutical Preparations), by market cap.

P/E vs peers

11.69 / 16.82 med

-30% discount

P/S vs peers

2.04 / 3.54 med

-42% discount

Net margin vs peers

17.5% / -0.1% med

above median

1–14 of 14


LLY	Lilly (Eli)	$1.04T	50.16	15.88	31.7%	-1.17%
JNJ	Johnson & Johnson	$549.8B	20.51	5.84	28.5%	-2.42%
ONC	Beone Medicines Ltd.	$390.6B	1361.26	73.10	5.4%	+2.83%
ABBV	AbbVie	$382.5B	90.51	6.25	6.9%	-2.16%
MRK	Merck	$281.6B	15.43	4.33	28.1%	-1.30%
ABT	Abbott Laboratories	$154.3B	23.65	3.48	14.7%	+0.09%
PFE	Pfizer	$143.7B	18.50	2.30	12.4%	-2.89%
VRTX	Vertex Pharmaceuticals	$114.6B	28.99	9.55	32.9%	-1.63%
BMY	Bristol Myers Squibb	$110.3B	15.63	2.29	14.6%	-2.35%
REGN	Regeneron Pharmaceuticals	$63.4B	14.08	4.42	31.4%	+0.38%
ALNY	Alnylam Pharmaceuticals	$36.9B	117.57	9.93	8.4%	-1.66%
TEVA	Teva Pharmaceutical Industries Ltd	$36.6B	25.98	2.12	8.2%	-3.33%
ZTS	Zoetis	$33.1B	12.37	3.49	28.2%	+2.09%
RPRX	Royalty Pharma Plc	$23.1B	30.02	9.73	32.4%	-1.30%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.